MBX Capital

CND Life Sciences specializes in developing diagnostic tools for neurodegenerative diseases, particularly focusing on synucleinopathy. The company has introduced the Syn-One Test, which is designed to detect, visualize, and quantify abnormal phosphorylated alpha-synuclein in cutaneous nerve fibers. This commercially available test serves as an objective diagnostic aid for confirming synucleinopathy in patients suspected of having conditions such as Parkinson’s disease, dementia with Lewy bodies, multiple system atrophy, or pure autonomic failure. By providing a convenient and minimally invasive method for diagnosis, CND Life Sciences enhances the ability of medical professionals to accurately identify these complex disorders.

Keebler Health is a technology company that specializes in medical coding assistance. It has developed an AI-driven platform designed to support medical billing teams. The platform, known as a medical coding co-pilot, helps identify and rectify inconsistencies and omissions in coding processes. This not only enhances the efficiency of coders, billers, auditors, and physicians but also helps reduce denial rates and safeguard providers from coding and billing errors, thereby improving overall reimbursement levels.

Tidal Vision Inc. is a manufacturer based in Ferndale, Washington, specializing in sustainable products derived from ocean waste, particularly salmon skin and crab shells. Founded in 2015, the company produces a range of offerings, including Alaska Salmon leather items such as wallets, belts, shoes, and boots, as well as a variety of chitosan-based products. Chitosan, a biodegradable industrial biopolymer extracted from crab shells, serves multiple applications, including as a fining agent for beverages, a water clarifier, and an antimicrobial agent. Tidal Vision employs a proprietary zero-waste extraction process, ensuring consistent quality and cost-effectiveness in its chitosan products. The company is recognized as a vertically integrated chitosan producer, developing ready-to-use formulations tailored for industries such as water treatment, textiles, and agriculture, thereby promoting environmentally friendly practices.

Waypoint Bio is a company focused on advancing cell therapy to treat solid tumors in cancer patients. It has developed a novel platform that integrates spatial multi-omics, utilizing proprietary methodologies enhanced by artificial intelligence and machine learning. This innovative approach facilitates the design of effective and safe cell therapies through pooled screening techniques. By optimizing the application of cell therapy, Waypoint Bio aims to improve treatment outcomes for patients battling solid tumors.

Vivodyne specializes in developing an automated robotic platform that aims to advance drug discovery and cellular therapies. The company's innovative microfluidic bioengineering technology facilitates the culture of highly realistic human tissue models, allowing researchers to explore complex biological processes. By employing single-cell 4D phenomics and integrating advanced imaging techniques, Vivodyne's system enables the formulation of tailored mixtures of compounds and cell therapies. This comprehensive approach not only accelerates the development of potential cures for various human diseases but also enhances the understanding of human health at a cellular level.

Forum is a digital platform that facilitates peer support groups, connecting individuals facing life's challenges with like-minded peers and trained facilitators. The company's online space enables users to engage in discussions, share experiences, and provide mutual support on a range of topics, from life transitions and career to health and relationships. By breaking down geographical barriers, Forum aims to make peer support more accessible, fostering personal growth, healing, and mental well-being.

Macro Trials develops a precision research clinical platform aimed at streamlining the process of bringing therapeutics to market. The company provides essential infrastructure to simplify distributed clinical trials, facilitating new site activation and site monitoring. By collaborating with pharmaceutical companies, physicians, and health systems, Macro Trials designs, plans, and executes clinical trials for high-value therapeutics, enhancing research velocity and enabling broader participant engagement. This approach not only improves the generalizability of research results but also generates valuable longitudinal patient records, contributing to the advancement of clinical research.

Thesis offers personalized brain supplements that cater to all types of brains. They create potent nutritional compounds to improve mental function and provide individualized suggestions depending on their customers' goals and brain chemistry.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

Freedom Biosciences is a biotechnology platform focused on developing next-generation psychedelic therapeutics. The company aims to create innovative psychedelic pharmaceuticals by utilizing the established pharmacology of ketamine and other psychedelic compounds. This approach is intended to equip medical professionals with effective treatment options for patients suffering from resistant depression and various mental disorders.

Arine Inc. is a San Francisco-based company that develops a medication management platform aimed at improving patient health and quality of life. Founded in 2017, Arine utilizes a clinical learning and analytic response engine to deliver data-driven clinical services. The platform aggregates and analyzes clinical, social, and behavioral data to identify and address gaps in patient care, providing tailored medication recommendations and education to patients and their care teams. By focusing on evidence-based approaches, Arine optimizes medication use, enhances patient outcomes, and aims to reduce the overall cost of care. Their commitment to continuous monitoring and evaluation ensures timely follow-up and meaningful clinical service programs, guiding patients throughout their healthcare journey.

OFFOR Health is an on-site care delivery platform that enhances access to healthcare by utilizing existing medical and dental facilities. The organization aims to address surgery backlogs and improve outcomes for Medicaid patients through its innovative approach. OFFOR Health specializes in providing pediatric dental anesthesia and is expanding its services into various areas, including Mobile Integrated Healthcare, community paramedicine, primary care driven by dental services, and vaccinations. By connecting healthcare professionals with patients in local communities, OFFOR Health strives to deliver specialist anesthesiology care and essential supplies directly to those in need, ultimately increasing accessibility and reducing healthcare costs.

SmileMD is an on-site anesthesia service company bringing anesthesia care teams and logistics to optimize the venue for surgeries. It provides anesthesia to pediatric and adult dental practices in their office setting, reducing anxiety and increasing access to care for thousands of patients each year. They utilize the same safety processes and procedures as hospitals, and our anesthesia care team allows us to provide the highest quality patient care efficiently and safely.

Atlas Labs, Inc. operates a technology platform designed to connect patients with various medical aid programs, aiming to minimize out-of-pocket expenses and alleviate the workload of financial counselors. The platform enhances revenue generation from third-party programs and assists patients in securing financial aid, while also facilitating reimbursement for medical providers on self-pay balances. By streamlining patient enrollment in external programs, Atlas Labs converts uncompensated care into revenue and automates financial assistance for those ineligible for certain programs. The company, incorporated in 2015 and headquartered in San Francisco, California, plays a crucial role in improving patient access to financial resources, demonstrating compliance, and addressing community healthcare needs.

Smiles.ai leverages proprietary technology and expert healthcare professionals to provide access to high-quality and cost-effective dental care products and services.

Freedom Biosciences is a biotechnology platform focused on developing next-generation psychedelic therapeutics. The company aims to create innovative psychedelic pharmaceuticals by utilizing the established pharmacology of ketamine and other psychedelic compounds. This approach is intended to equip medical professionals with effective treatment options for patients suffering from resistant depression and various mental disorders.

Contraline, Inc. is a biotechnology company based in Charlottesville, Virginia, focused on developing male birth control solutions. The company is creating an innovative, long-lasting, non-hormonal, and reversible contraceptive known as Echo-V. This product consists of an ultrasound-visible polymer solution that is injected into the vas deferens, forming a polymer hydrogel device. This device acts as a semi-permeable membrane, effectively blocking sperm while allowing bodily fluids to pass through. Contraline also offers Vasintomy, a non-surgical procedure for the insertion of Echo-V, providing a cost-effective and user-friendly approach to male contraception. Founded in 2015, Contraline aims to transform male reproductive health through its groundbreaking technology.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Attivare Therapeutics focuses on the development of biomaterial-based vaccines aimed at enhancing immune responses against tumors that exhibit low immunogenicity. The company’s innovative approach involves creating a specialized microenvironment within the body that concentrates immune cells and delivers immunomodulatory agents to these cells. This strategy is designed to effectively reprogram the immune response, breaking tolerance to cancer antigens. By leveraging this technology, Attivare Therapeutics enables researchers to develop bioactive components that significantly improve the magnitude and durability of immune responses in patients.

CareRev is a healthcare staffing marketplace that connects medical facilities directly with per diem healthcare professionals, eliminating the need for vendors or agencies. Its online platform allows hospitals and outpatient facilities to efficiently fill shifts by accessing a pool of flexible clinical talent. This model not only expedites the staffing process but also helps facilities reduce costs and maintain appropriate nurse-to-patient ratios, ultimately enhancing the quality of patient care. By facilitating direct communication between healthcare providers and staff, CareRev empowers professionals to choose their work schedules and locations, promoting greater flexibility in the healthcare workforce. The company has received funding from notable investors, including Y Combinator and several prominent business angels.

Vital Bio is focused on transforming lab testing to make healthcare more accessible and personalized. The company develops advanced diagnostic technologies that connect diagnosis and treatment through a comprehensive ecosystem of devices, software, and services. By empowering patients to monitor their health and manage diseases, Vital Bio aims to enhance the overall healthcare experience. Their approach seeks to reduce disparities in healthcare outcomes and redistribute control to patients while equipping healthcare providers with the tools necessary to achieve better results.

ixlayer is a prominent player in the health-tech sector, specializing in virtual health testing solutions for health systems, payors, biopharma, and health-focused organizations. Founded in 2018, the company provides a comprehensive platform that addresses the technical, security, regulatory, and user experience aspects of complex health testing. As the healthcare landscape increasingly embraces remote care, ixlayer enhances patient engagement and supports preventative health strategies through scalable virtual testing options. The platform can be integrated into existing patient engagement systems and portals, facilitating real-time health and wellness lab testing. ixlayer currently serves millions of patients and has successfully launched numerous testing programs for major organizations, health systems, and government entities.

AmacaThera Inc. is a clinical-stage biotechnology company based in Toronto, Canada, established in 2016. The company focuses on developing and commercializing an injectable hydrogel technology designed to enhance drug delivery for various medical applications. This innovative platform aims to improve patient outcomes in areas such as post-surgical pain management, cancer treatment, and other challenging therapeutic targets. AmacaThera's technology features a fast-gelling material that transitions from a liquid to a gel under force, combining hyaluronan and methylcellulose. This unique formulation allows for localized and sustained drug delivery, ultimately assisting healthcare providers in effectively managing patients' pain following surgery.

Concert Health, Inc. is a company that develops and operates an online platform designed to connect physicians with therapists and psychiatrists, facilitating the integration of behavioral health services into primary care practices. Founded in 2016 and headquartered in San Diego, California, the company provides a range of services including remote clinical staffing with behavioral care managers and psychiatric consultants, as well as tools for registry, screening, workflow management, and reimbursement. Concert Health emphasizes evidence-based care by assisting medical groups in implementing shared care plans that address both physical and mental health needs. By working closely with primary care teams, Concert Health aims to enhance the quality of behavioral health care through effective documentation and billing support, ultimately improving patient outcomes.

Earli is a company focused on developing innovative cancer treatment devices that utilize synthetic biomarkers for early cancer detection. The company's approach involves a novel gene therapy technique known as Synthetic Biopsy, which prompts cancer cells to produce synthetic, non-human biomarkers. These biomarkers can be detected through various means, including blood, urine, or breath, allowing for timely tracking and treatment of cancer. By facilitating the early identification of cancer when it is still homogeneous, Earli aims to significantly enhance survival rates. Their technology not only aids in detection but is also applicable for therapeutic interventions, thereby personalizing treatment and improving patient outcomes.

SecureAire is a developer of advanced active particle control technology aimed at enhancing air filtration efficiency. This innovative technology effectively removes small, critical particles, including bacteria, viruses, allergens, volatile organic compounds (VOCs), gases, and odors from indoor environments. By significantly reducing or eliminating these harmful particles, SecureAire's solutions help hospitals, commercial buildings, and residential spaces improve air quality, mitigate the risks associated with sick building syndrome, and curb the spread of dangerous airborne pathogens.

Koneksa Health Inc. is a healthcare data analytics company focused on enhancing clinical studies and disease research through the use of remotely generated patient data. The company's software, Koneksa Compare, facilitates the collection, visualization, and analysis of patient-generated data, incorporating emerging technologies such as bio-sensors, activity trackers, and mobile-based questionnaires. This platform allows pharmaceutical and biotech companies, as well as academic researchers, to make informed decisions and regulatory claims based on objective data. Koneksa also provides biometric devices that generate electronic clinical outcome assessments and offers a dashboard for monitoring patient engagement, which includes reminders for study subjects. Founded in 2013 and headquartered in New York, Koneksa has an additional office in London, United Kingdom.

Atlas Labs, Inc. operates a technology platform designed to connect patients with various medical aid programs, aiming to minimize out-of-pocket expenses and alleviate the workload of financial counselors. The platform enhances revenue generation from third-party programs and assists patients in securing financial aid, while also facilitating reimbursement for medical providers on self-pay balances. By streamlining patient enrollment in external programs, Atlas Labs converts uncompensated care into revenue and automates financial assistance for those ineligible for certain programs. The company, incorporated in 2015 and headquartered in San Francisco, California, plays a crucial role in improving patient access to financial resources, demonstrating compliance, and addressing community healthcare needs.

Brightside is a financial health company that offers an employer-based platform focused on improving the financial well-being of workers, particularly those living paycheck to paycheck. The platform addresses challenges faced by front-line workers, such as high turnover, healthcare costs, and productivity issues. Brightside provides tailored financial solutions supported by technology-driven financial assistants and a comprehensive app. This approach personalizes services to meet the individual needs of employees and their families, promoting better financial decision-making through behavioral science. By streamlining access to curated financial products, Brightside aims to enhance employee productivity and retention while contributing to a more diverse and equitable workplace.

Wellth is a digital health company based in New York that aims to enhance treatment adherence among individuals with chronic conditions. By leveraging behavioral economics, Wellth addresses the barriers that hinder patients from forming healthy habits and effectively managing their diseases. The company operates a mobile application that provides targeted incentive plans, reminders, and information to motivate users to engage in preventive health behaviors. Its platform not only empowers consumers to improve their adherence to medication and care plans but also helps reduce preventable hospitalizations and healthcare costs. Wellth's approach includes proven outcomes demonstrated through randomized controlled trials, making it a valuable solution for insurers and healthcare providers seeking to improve population health. Through its user-friendly application, Wellth supports members in establishing sustainable healthy habits while generating cost savings for payors.

Lucy Goods, Inc. is a manufacturer and seller of nicotine gum and lozenges, providing alternatives to traditional tobacco products. Founded in 2016 and headquartered in Los Angeles, California, the company focuses on reducing tobacco-related harm by offering next-generation nicotine products made with pure nicotine and food-grade ingredients. Lucy Goods provides its offerings in various flavors, including fruit, mint, and cinnamon, and sells its products primarily through online channels. The company aims to deliver a cleaner and more convenient alternative to existing nicotine products on the market.

CloudCath is a company that specializes in developing a remote monitoring platform for peritoneal dialysis patients. Their innovative system utilizes sensor-enabled technology to provide continuous monitoring, allowing for early detection of complications associated with catheter-based treatments. By leveraging Internet of Things (IoT) capabilities, CloudCath's platform enables healthcare providers to remotely oversee patients during their home treatment, significantly reducing the frequency of in-person visits. This approach not only enhances patient safety but also improves the overall management of care for individuals undergoing peritoneal dialysis, ultimately promoting better health outcomes.

Luna operates a health and wellness center specializing in physical therapies aimed at addressing various conditions such as orthopedic and sports injuries, senior care, post-surgical rehabilitation, and pain management. The company seeks to enhance the effectiveness of physical therapy by providing greater access to care for patients while offering therapists the autonomy and flexibility necessary to manage their careers effectively. Recognizing the challenges faced by both therapists and patients, Luna is committed to creating an environment that fosters independence and motivation, ultimately leading to improved outcomes and greater satisfaction in the therapy process.

Uniform Teeth is an orthodontics practice focused on providing modern and accessible orthodontic care. The company operates dental clinics that specialize in clear teeth aligners, which are crafted from biocompatible, BPA-free plastic designed to fit the patient's teeth at each stage of treatment. By prioritizing quality and intuitiveness in their services, Uniform Teeth aims to simplify the orthodontic experience for patients seeking to straighten their teeth.

Meissa Vaccines, Inc. is a pharmaceutical development company based in San Mateo, California, established in 2014. The company focuses on advancing vaccines for respiratory syncytial virus (RSV), rhinovirus, and human metapneumovirus, addressing significant unmet medical needs, particularly in pediatrics. By in-licensing and developing these vaccines, Meissa Vaccines aims to mitigate the impact of respiratory illnesses, which are leading causes of infectious disease globally. The successful implementation of their vaccine programs could greatly reduce the incidence of acute lower respiratory tract diseases, alleviate symptoms associated with colds and asthma exacerbations, and ultimately lessen the burden on families by minimizing school and work absenteeism. The company's initiatives not only prioritize child health but also have the potential to benefit various age groups within the community.

Buoy Health, Inc. is a health technology company based in Boston, Massachusetts, with an additional office in New York. Founded in 2014, Buoy Health specializes in artificial intelligence-driven digital health solutions that assist individuals in managing their health and healthcare options. The company offers a personalized online healthcare chatbot, known as Buoy Assistant, which analyzes symptoms, facilitates initial triage, and provides treatment recommendations. This platform enables users to conduct real-time assessments of their symptoms while simplifying the navigation of the healthcare system. Additionally, Buoy Health provides resources for employees through its Buoy Dashboard, allowing them to research benefits, access wellness programs, and connect with in-network providers. The service is available 24/7, making self-diagnosis and healthcare navigation straightforward and accessible.

Osmosis is a personalized learning platform focused on enhancing health education by providing a deeper understanding of medical concepts. The platform enables clinicians and caregivers to access a wealth of educational resources, including a comprehensive library of videos and multiple-choice questions. Driven by data and technology, Osmosis aims to improve retention and preparedness for courses and exams, making it a valuable tool for medical professionals seeking to deepen their knowledge and skills in the healthcare field. By offering tailored content that goes beyond traditional lectures, Osmosis supports effective learning for a global audience in the medical community.

Mightier is a gaming platform designed to assist children in regulating their emotions through scientifically-backed methods. Founded in 2016 and based in Boston, Massachusetts, the platform features bioresponsive video games developed in collaboration with Boston Children's Hospital and Harvard Medical School. The games utilize a biofeedback heart rate monitor that adjusts the difficulty level based on the player's emotional state, helping children learn to manage their feelings in real-time. By engaging with these interactive experiences, children with behavioral and emotional challenges can discover their emotional strengths and develop skills to harness their emotions in everyday situations.

SafeRide Health is a healthcare technology platform that focuses on enhancing medical transportation and care coordination for vulnerable populations. The company provides a comprehensive platform that empowers health plans to manage their members effectively, ensuring greater intelligence and control over services. By utilizing advanced technology and artificial intelligence, SafeRide Health facilitates end-to-end data transparency, which in turn improves patient experiences and outcomes. The platform aims to transform the patient journey, enhance population health, and reduce overall healthcare costs through its innovative solutions, including patented fleet management capabilities tailored to the healthcare industry.

SPARK Neuro Inc. is a neuroscience company based in New York, founded in 2013. It specializes in market research for the advertising and entertainment industries, utilizing neuroscience tools to enhance audience engagement and storytelling. Additionally, SPARK Neuro focuses on analyzing brain activity to improve clinical care and therapeutic discovery. The company partners with prestigious institutions to develop its patented neural metrics and advanced machine learning algorithms, exemplified by the SPARK Scan, a 10-minute EEG-based evaluation that helps identify early signs of changes in brain health. Through its innovative platform, SPARK Neuro aims to make brain health measurement universally accessible, enabling healthcare professionals to better understand and address neurological and psychiatric conditions.

Opentrons is a company that specializes in the development of pipetting robot technology aimed at automating laboratory experiments. By utilizing open-source principles, Opentrons provides a range of lab automation solutions, including robots, workstations, hardware modules, consumables, reagents, and labware. Their technology leverages the Python programming language to streamline experimental processes, making them faster and reducing the likelihood of human error. This focus on automation allows scientific researchers to enhance efficiency and accuracy in their work, ultimately advancing their research capabilities.

Sonavex, Inc. is a Baltimore-based company founded in 2013 that specializes in advanced imaging technology aimed at enhancing surgical outcomes. The company has developed a proprietary ultrasound-based platform that enables clinicians to detect anastomotic blood clots and assess critical intravascular flow metrics directly at the point of care. This technology not only facilitates the measurement of blood flow and vessel morphology but also includes bioresorbable and echogenic equipment to mark at-risk blood vessels for future assessments. By providing actionable data, Sonavex supports healthcare providers in monitoring and improving patient care, particularly in the context of post-operative complications.

SwiftShift Ltd. is a London-based company founded in 2012 that specializes in real-time workforce management solutions for the healthcare sector, specifically focusing on pediatric home care. The company addresses the increasing demand for pediatric home care, which is often more effective and economical than institutional care. SwiftShift offers a unique, nurse-managed delivery service that empowers nurses by replacing traditional office-based case managers with self-managed care teams. These teams have the autonomy to select their patients and control their schedules, fostering a greater sense of ownership in care management. Utilizing an AI-based home care management platform, SwiftShift enhances the efficiency of care delivery by providing nurses with easy access to relevant data, enabling better decision-making for patient well-being. The company is dedicated to improving patient outcomes through exceptional nursing experiences, offering continuous training and support to its nursing staff, thereby ensuring they are well-equipped to provide high-quality care.

EpiBone, Inc. is a biotechnology company based in Brooklyn, New York, focused on developing advanced solutions for bone and cartilage repair. Founded in 2013, EpiBone utilizes patient-specific scans and their own stem cells to create customized bone grafts, which are cultivated in a bioreactor to facilitate growth. The company aims to improve skeletal repair and enhance bone formation and regeneration through its innovative technologies. EpiBone's lead product, a living 3D bone graft, successfully completed its Phase I/IIa clinical trial in August 2023. Additionally, the company is advancing its cartilage repair pipeline, which includes an allogeneic osteochondral plug that received Investigational New Drug approval in July 2023, and an injectable cartilage filler, partly funded by the Department of Defense. Through these developments, EpiBone seeks to revolutionize orthopedic repair and provide patients with more effective treatment options.

Perceptive Navigation LLC is a pre-clinical stage medical device company based in Baltimore, Maryland, focused on developing interventional medical devices for image-guided surgery. Its flagship product, Vu-Path, is an innovative intracorporeal ultrasound device that combines forward-viewing ultrasound imaging with a working portal for the introduction of needles, biopsy instruments, guide wires, and therapeutic delivery. Designed to enhance the safety and efficacy of minimally invasive procedures across various medical specialties, including radiology, cardiology, interventional oncology, and urology, Vu-Path addresses critical limitations of existing imaging techniques, which can be costly, cumbersome, and risky. The device aims to provide accurate and precise access to internal structures, thereby reducing procedural times and enhancing overall patient care. By replacing traditional imaging methods like surface ultrasound, CT, X-Ray, and MRI, Vu-Path is positioned to streamline complex surgical operations while minimizing resource requirements. Perceptive Navigation was incorporated in 2012 and continues to advance its technology to meet the needs of the medical community.

MHB Labs is a biotechnology company based in Chestnut Hill, Massachusetts, focused on developing innovative men's health products. Established in 1999, the company specializes in creating pharmaceutical solutions for conditions such as erectile dysfunction, Peyronie’s disease, and delayed orgasm. Its key product, AndroSphere, aims to enhance men's health by addressing these unmet medical needs. Additionally, MHB Labs collaborates with various partners, including a medical device start-up and a telemedicine company, to expand its product offerings and improve patient access to healthcare. The company leverages clinical insights and strategic alliances to advance its research and development initiatives, positioning itself to bring high-impact products to market effectively.

Persist AI specializes in enhancing the drug development process for pharmaceutical companies by utilizing artificial intelligence and automation technologies. By focusing on long-acting formulations, the company aims to significantly reduce the time required for pre-clinical formulation development from several years to just three months. This acceleration is achieved through methods such as automated drug release testing and high-throughput formulation screening. By streamlining these processes, Persist AI enables drug manufacturers to develop formulations 50% faster, ultimately contributing to improved patient outcomes and more efficient drug development.

Catena Biosciences is a biotechnology company focused on advancing protein conjugation technology to develop novel therapeutics for autoimmune disorders, oncology, and vaccine development. The company specializes in the efficient and selective attachment of proteins using natural amino acids, specifically tyrosine and cysteine. This innovative approach allows researchers to create biologic structures more rapidly than traditional methods, enhancing the potential for medical research and treatment options in various disease areas. Catena Biosciences aims to contribute significantly to the field of biomedicine through its cutting-edge technology and applications.

Vivodyne specializes in developing an automated robotic platform that aims to advance drug discovery and cellular therapies. The company's innovative microfluidic bioengineering technology facilitates the culture of highly realistic human tissue models, allowing researchers to explore complex biological processes. By employing single-cell 4D phenomics and integrating advanced imaging techniques, Vivodyne's system enables the formulation of tailored mixtures of compounds and cell therapies. This comprehensive approach not only accelerates the development of potential cures for various human diseases but also enhances the understanding of human health at a cellular level.